Old | New | Differences | |
---|---|---|---|
1 | 1 | ||
2 | 2 | ||
3 | 3 | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
4 | 4 | [Brackets] indicate matter deleted from existing law. | |
5 | - | Underlining indicates amendments to bill. | |
6 | - | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
7 | - | amendment. | |
8 | 5 | *hb0879* | |
9 | 6 | ||
10 | 7 | HOUSE BILL 879 | |
11 | 8 | J5 4lr2511 | |
12 | 9 | CF SB 595 | |
13 | - | By: Delegates S. Johnson and A. Johnson, A. Johnson, Alston, Bagnall, Bhandari, | |
14 | - | Chisholm, Cullison, Guzzone, Hill, Hutchinson, Kaiser, Kipke, R. Lewis, | |
15 | - | Lopez, Martinez, M. Morgan, Pena–Melnyk, Reilly, Rosenberg, Szeliga, | |
16 | - | Taveras, White Holland, and Woods | |
10 | + | By: Delegates S. Johnson and A. Johnson | |
17 | 11 | Introduced and read first time: February 2, 2024 | |
18 | 12 | Assigned to: Health and Government Operations | |
19 | - | Committee Report: Favorable with amendments | |
20 | - | House action: Adopted | |
21 | - | Read second time: March 1, 2024 | |
22 | 13 | ||
23 | - | ||
14 | + | A BILL ENTITLED | |
24 | 15 | ||
25 | 16 | AN ACT concerning 1 | |
26 | 17 | ||
27 | 18 | Health Benefit Plans – Calculation of Cost Sharing Contribution – 2 | |
28 | 19 | Requirements and Prohibitions 3 | |
29 | 20 | ||
30 | - | FOR the purpose of requiring certain insurers, nonprofit health service plans, and health 4 | |
31 | - | maintenance organizations to include certain discounts, financial assistance 5 | |
32 | - | payments, product vouchers, and other out–of–pocket expenses made by or on behalf 6 | |
33 | - | of an insured or enrollee when calculating certain cost–sharing contributions for 7 | |
34 | - | certain prescription drugs; requiring persons that provide certain discounts, 8 | |
35 | - | financial assistance payments, product vouchers, or other out–of–pocket expenses to 9 | |
36 | - | notify an insured or enrollee of certain information; providing that a violation of a 10 | |
37 | - | certain provision of this Act is considered a violation of the Consumer Protection Act; 11 | |
38 | - | administrators, carriers, and pharmacy benefits managers to include certain cost 12 | |
39 | - | sharing amounts paid by or on behalf of an enrollee or a beneficiary when calculating 13 | |
40 | - | the enrollee’s or beneficiary’s contribution to a cost sharing requirement; requiring 14 | |
41 | - | administrators, carriers, and pharmacy benefits managers to include certain cost 15 | |
42 | - | sharing amounts for certain high deductible health plans after an enrollee or a 16 | |
43 | - | beneficiary satisfies a certain requirement; prohibiting administrators, carriers, and 17 | |
44 | - | pharmacy benefits managers from directly or indirectly setting, altering, 18 | |
45 | - | implementing, or conditioning the terms of certain coverage based on certain 19 | |
46 | - | information; and generally relating to the calculation of cost sharing requirements. 20 | |
21 | + | FOR the purpose of requiring administrators, carriers, and pharmacy benefits managers to 4 | |
22 | + | include certain cost sharing amounts paid by or on behalf of an enrollee or a 5 | |
23 | + | beneficiary when calculating the enrollee’s or beneficiary’s contribution to a cost 6 | |
24 | + | sharing requirement; requiring administrators, carriers, and pharmacy benefits 7 | |
25 | + | managers to include certain cost sharing amounts for certain high deductible health 8 | |
26 | + | plans after an enrollee or a beneficiary satisfies a certain requirement; prohibiting 9 | |
27 | + | administrators, carriers, and pharmacy benefits managers from directly or indirectly 10 | |
28 | + | setting, altering, implementing, or conditioning the terms of certain coverage based 11 | |
29 | + | on certain information; and generally relating to the calculation of cost sharing 12 | |
30 | + | requirements. 13 | |
47 | 31 | ||
48 | - | BY adding to 21 2 HOUSE BILL 879 | |
32 | + | BY adding to 14 | |
33 | + | Article – Insurance 15 | |
34 | + | Section 15–118.1 and 15–1611.3 16 | |
35 | + | Annotated Code of Maryland 17 | |
36 | + | (2017 Replacement Volume and 2023 Supplement) 18 | |
49 | 37 | ||
38 | + | BY repealing and reenacting, with amendments, 19 | |
39 | + | Article – Insurance 20 | |
40 | + | Section 15–1601 21 | |
41 | + | Annotated Code of Maryland 22 | |
42 | + | (2017 Replacement Volume and 2023 Supplement) 23 | |
50 | 43 | ||
51 | - | Article – Insurance 1 | |
52 | - | Section 15–118.1 and 15–1611.3 2 | |
53 | - | Annotated Code of Maryland 3 | |
54 | - | (2017 Replacement Volume and 2023 Supplement) 4 | |
44 | + | Preamble 24 | |
55 | 45 | ||
56 | - | BY repealing and reenacting, with amendments, 5 | |
57 | - | Article – Insurance 6 | |
58 | - | Section 15–1601 7 | |
59 | - | Annotated Code of Maryland 8 | |
60 | - | (2017 Replacement Volume and 2023 Supplement) 9 | |
61 | - | ||
62 | - | Preamble 10 | |
63 | - | ||
64 | - | WHEREAS, Residents of Maryland frequently rely on State–regulated commercial 11 | |
65 | - | health insurance carriers to secure access to the prescription medicines needed to protect 12 | |
66 | - | their health; and 13 | |
67 | - | ||
68 | - | WHEREAS, Commercial health insurance designs increasingly require patients to 14 | |
69 | - | bear significant out–of–pocket costs for their prescription medicines; and 15 | |
70 | - | ||
71 | - | WHEREAS, High out–of–pocket costs on prescription medicines impact the ability 16 | |
72 | - | of patients to start new and necessary medicines and to stay adherent to their current 17 | |
73 | - | prescriptions; and 18 | |
74 | - | ||
75 | - | WHEREAS, High or unpredictable cost sharing requirements are a main driver of 19 | |
76 | - | elevated patient out–of–pocket costs and allow health insurance carriers to capture 20 | |
77 | - | discounts and price concessions that are intended to benefit patients at the pharmacy 21 | |
78 | - | counter; and 22 | |
79 | - | ||
80 | - | WHEREAS, Health insurance carriers unfairly increase cost sharing burdens on 23 | |
81 | - | patients by refusing to count third–party assistance toward patients’ cost sharing 24 | |
82 | - | contributions; and 25 | |
83 | - | ||
84 | - | WHEREAS, The burdens of high or unpredictable cost sharing requirements are 26 | |
85 | - | borne disproportionately by patients with chronic or debilitating conditions; and 27 | |
86 | - | ||
87 | - | WHEREAS, Restrictions are needed on the ability of health insurance carriers and 28 | |
88 | - | their intermediaries to use unfair cost sharing designs to retain rebates and price 29 | |
89 | - | concessions that instead should be directly passed on to patients as cost savings; and 30 | |
90 | - | ||
91 | - | WHEREAS, Patients need equitable and accessible health coverage that does not 31 | |
92 | - | impose unfair cost sharing burdens on them; now, therefore, 32 | |
93 | - | ||
94 | - | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 33 | |
95 | - | That the Laws of Maryland read as follows: 34 | |
96 | - | ||
97 | - | Article – Insurance 35 HOUSE BILL 879 3 | |
46 | + | WHEREAS, Residents of Maryland frequently rely on State–regulated commercial 25 | |
47 | + | health insurance carriers to secure access to the prescription medicines needed to protect 26 | |
48 | + | their health; and 27 2 HOUSE BILL 879 | |
98 | 49 | ||
99 | 50 | ||
100 | 51 | ||
101 | - | 15–118.1. 1 | |
52 | + | WHEREAS, Commercial health insurance designs increasingly require patients to 1 | |
53 | + | bear significant out–of–pocket costs for their prescription medicines; and 2 | |
102 | 54 | ||
103 | - | (A) (1) THIS SECTION APPLIES TO: 2 | |
55 | + | WHEREAS, High out–of–pocket costs on prescription medicines impact the ability 3 | |
56 | + | of patients to start new and necessary medicines and to stay adherent to their current 4 | |
57 | + | prescriptions; and 5 | |
104 | 58 | ||
105 | - | | |
106 | - | ||
107 | - | ||
108 | - | ||
59 | + | WHEREAS, High or unpredictable cost sharing requirements are a main driver of 6 | |
60 | + | elevated patient out–of–pocket costs and allow health insurance carriers to capture 7 | |
61 | + | discounts and price concessions that are intended to benefit patients at the pharmacy 8 | |
62 | + | counter; and 9 | |
109 | 63 | ||
110 | - | | |
111 | - | ||
112 | - | ||
64 | + | WHEREAS, Health insurance carriers unfairly increase cost sharing burdens on 10 | |
65 | + | patients by refusing to count third–party assistance toward patients’ cost sharing 11 | |
66 | + | contributions; and 12 | |
113 | 67 | ||
114 | - | (2) AN INSURER, A NONPROFIT HEALTH S ERVICE PLAN, OR A HEALTH 10 | |
115 | - | MAINTENANCE ORGANIZA TION THAT PROVIDES C OVERAGE FOR PRESCRIP TION 11 | |
116 | - | DRUGS THR OUGH A PHARMACY BENE FITS MANAGER IS SUBJ ECT TO THE 12 | |
117 | - | REQUIREMENTS OF THIS SECTION. 13 | |
68 | + | WHEREAS, The burdens of high or unpredictable cost sharing requirements are 13 | |
69 | + | borne disproportionately by patients with chronic or debilitating conditions; and 14 | |
118 | 70 | ||
119 | - | (B) (1) SUBJECT TO PARAGRAPH (2) OF THIS SUBSECTION , WHEN 14 | |
120 | - | CALCULATING AN INSUR ED’S OR ENROLLEE ’S CONTRIBUTION TO TH E INSURED’S OR 15 | |
121 | - | ENROLLEE’S COINSURANCE , COPAYMENT , DEDUCTIBLE, OR OUT–OF–POCKET 16 | |
122 | - | MAXIMUM UNDER THE IN SURED’S OR ENROLLEE ’S HEALTH BENEFIT PLA N, AN 17 | |
123 | - | ENTITY SUBJECT TO TH IS SECTION SHALL INC LUDE ANY DISCOUNT , FINANCIAL 18 | |
124 | - | ASSISTANCE PAYMENT , PRODUCT VOUCHER , OR OTHER OUT –OF–POCKET EXPENSE 19 | |
125 | - | MADE BY OR ON BEHALF OF THE INSU RED OR ENROLLEE FOR A PRESCRIPTION 20 | |
126 | - | DRUG: 21 | |
71 | + | WHEREAS, Restrictions are needed on the ability of health insurance carriers and 15 | |
72 | + | their intermediaries to use unfair cost sharing designs to retain rebates and price 16 | |
73 | + | concessions that instead should be directly passed on to patients as cost savings; and 17 | |
127 | 74 | ||
128 | - | | |
129 | - | ||
75 | + | WHEREAS, Patients need equitable and accessible health coverage that does not 18 | |
76 | + | impose unfair cost sharing burdens on them; now, therefore, 19 | |
130 | 77 | ||
131 | - | (II) 1. THAT DOES NOT HAVE A N AB–RATED GENERIC 24 | |
132 | - | EQUIVALENT DRUG OR A N INTERCHANGEABLE BI OLOGICAL PRODUCT PRE FERRED 25 | |
133 | - | UNDER THE HEALTH BENEFIT PLAN ’S FORMULARY ; OR 26 | |
78 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 20 | |
79 | + | That the Laws of Maryland read as follows: 21 | |
134 | 80 | ||
135 | - | 2. A. THAT HAS AN AB–RATED GENERIC 27 | |
136 | - | EQUIVALENT DRUG OR A N INTERCHANGEABLE BI OLOGICAL PRODUCT PRE FERRED 28 | |
137 | - | UNDER THE HEALTH BEN EFIT PLAN’S FORMULARY ; AND 29 | |
81 | + | Article – Insurance 22 | |
138 | 82 | ||
139 | - | B. FOR WHICH THE INSURE D OR ENROLLEE ORIGIN ALLY 30 | |
140 | - | OBTAINED COVE RAGE THROUGH PRIOR A UTHORIZATION , A STEP THERAPY 31 | |
141 | - | PROTOCOL, OR THE EXCEPTION OR APPEAL PROCESS OF TH E ENTITY SUBJECT TO 32 | |
142 | - | THIS SECTION. 33 | |
83 | + | 15–118.1. 23 | |
84 | + | ||
85 | + | (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 24 | |
86 | + | INDICATED. 25 | |
87 | + | ||
88 | + | (2) “ADMINISTRATOR ” HAS THE MEANING STAT ED IN § 8–301 OF THIS 26 | |
89 | + | ARTICLE. 27 | |
90 | + | ||
91 | + | (3) “CARRIER” MEANS AN ENTITY SUBJ ECT TO THE JURISDICT ION OF 28 | |
92 | + | THE COMMISSIONER THAT CON TRACTS, OR OFFERS TO CONTRAC T, TO PROVIDE, 29 | |
93 | + | DELIVER, ARRANGE FOR , PAY FOR, OR REIMBURSE ANY OF THE COSTS OF HEALTH 30 | |
94 | + | CARE SERVICES UNDER A HEALTH BENEFIT PLA N IN THE STATE. 31 | |
95 | + | HOUSE BILL 879 3 | |
96 | + | ||
97 | + | ||
98 | + | (4) “COST SHARING ” MEANS ANY COPAYMENT , COINSURANCE , 1 | |
99 | + | DEDUCTIBLE, OR OTHER SIMILAR CHA RGE REQUIRED OF AN E NROLLEE FOR A 2 | |
100 | + | HEALTH CARE SERVICE COVERED BY A HEALTH BENEFIT PLAN , INCLUDING A 3 | |
101 | + | PRESCRIPTION DRUG , AND PAID BY OR ON BE HALF OF THE ENROLLEE . 4 | |
102 | + | ||
103 | + | (5) “ENROLLEE” MEANS AN INDIVIDUAL ENTITLED TO PAYMENT FOR 5 | |
104 | + | HEALTH CARE SERVICES FROM AN ADMINISTRATO R OR A CARRIER. 6 | |
105 | + | ||
106 | + | (6) “HEALTH BENEFIT PLAN ” MEANS A POLICY , A CONTRACT , A 7 | |
107 | + | CERTIFICATION , OR AN AGREEMENT OFFE RED OR ISSUED BY AN ADMINISTRATOR 8 | |
108 | + | OR A CARRIER TO PROVIDE , DELIVER, ARRANGE FOR , PAY FOR, OR REIMBURSE ANY 9 | |
109 | + | OF THE COSTS OF HEAL TH CARE SERVICES . 10 | |
110 | + | ||
111 | + | (7) “HEALTH CARE SERVICE ” MEANS AN ITEM OR SER VICE PROVIDED 11 | |
112 | + | TO AN INDIVIDUAL FOR THE PURPOSE OF PREVE NTING, ALLEVIATING, CURING, OR 12 | |
113 | + | HEALING HUMAN I LLNESS, INJURY, OR PHYSICAL DISABILI TY. 13 | |
114 | + | ||
115 | + | (B) THE ANNUAL LIMITATION ON COST SHARING PROV IDED FOR UNDER 42 14 | |
116 | + | U.S.C. § 18022(C)(1) SHALL APPLY TO ALL H EALTH CARE SERVICES COVERED 15 | |
117 | + | UNDER A HEALTH BENEF IT PLAN OFFERED OR I SSUED BY AN ADMINIST RATOR OR A 16 | |
118 | + | CARRIER IN THE STATE. 17 | |
119 | + | ||
120 | + | (C) (1) SUBJECT TO PARAGRAPHS (2) AND (3) OF THIS SUBSECTION , 18 | |
121 | + | WHEN CALCULATING AN ENROLLEE’S CONTRIBUTION TO AN APPLICABLE COST 19 | |
122 | + | SHARING REQUIREMENT , AN ADMINISTRATOR OR A CARRIER SHALL INCL UDE COST 20 | |
123 | + | SHARING AMOUNTS PAID BY THE ENROLLEE OR O N BEHALF OF THE ENRO LLEE BY 21 | |
124 | + | ANOTHER PERSON . 22 | |
125 | + | ||
126 | + | (2) IF THE APPLICATION OF THE REQUIREMENT UNDE R PARAGRAPH 23 | |
127 | + | (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS ACCOUNT 24 | |
128 | + | INELIGIBILITY UNDER § 223 OF THE INTERNAL REVENUE CODE, THE REQUIREMENT 25 | |
129 | + | SHALL APPLY TO HEALT H SAVINGS ACCOUNT –QUALIFIED HIGH DEDUCTIB LE 26 | |
130 | + | HEALTH PLANS WITH RE SPECT TO THE DEDUCTI BLE OF THE PLAN AFTE R THE 27 | |
131 | + | ENROLLEE SATISFIES T HE MINIMUM DEDUCTIBL E UNDER § 223 OF THE INTERNAL 28 | |
132 | + | REVENUE CODE. 29 | |
133 | + | ||
134 | + | (3) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 30 | |
135 | + | ACCORDANCE WITH § 223(C)(2)(C) OF THE INTERNAL REVENUE CODE, THE 31 | |
136 | + | REQUIREMENTS OF THIS SUBSECTION SHALL APP LY REGARDLESS OF WHE THER THE 32 | |
137 | + | ENROLLEE SATISFIES T HE MINIMUM DEDUCTIBL E UNDER § 223 OF THE INTERNAL 33 | |
138 | + | REVENUE CODE. 34 | |
143 | 139 | 4 HOUSE BILL 879 | |
144 | 140 | ||
145 | 141 | ||
146 | - | (2) IF AN INSURED OR ENRO LLEE IS COVERED UNDE R A 1 | |
147 | - | HIGH–DEDUCTIBLE HEALTH PL AN, AS DEFINED IN 26 U.S.C. § 223, THIS 2 | |
148 | - | SUBSECTION DOES NOT APPL Y TO THE DEDUCTIBLE REQUIREMENT OF THE 3 | |
149 | - | HIGH–DEDUCTIBLE HEALTH PL AN. 4 | |
142 | + | (D) AN ADMINISTRATOR OR A CARRIER MAY NOT DIRECTLY OR INDIRECTLY 1 | |
143 | + | SET, ALTER, IMPLEMENT, OR CONDITION THE TER MS OF HEALTH BENEFIT PLAN 2 | |
144 | + | COVERAGE, INCLUDING THE BENEFI T DESIGN, BASED IN WHOLE OR IN PART ON 3 | |
145 | + | INFORMATION ABOUT TH E AVAILABILITY OR AM OUNT OF FINANCIAL OR PRODUCT 4 | |
146 | + | ASSISTANCE AVAILABLE FOR A PRESCRIPTION D RUG. 5 | |
150 | 147 | ||
151 | - | (C) (1) A PERSON THAT PROVIDES A DISCOUNT, FINANCIAL ASSISTANCE 5 | |
152 | - | PAYMENT, PRODUCT VOUCHER , OR OTHER OUT –OF–POCKET EXPENSE MADE BY OR 6 | |
153 | - | ON BEHALF OF THE INS URED OR ENROL LEE THAT IS USED IN THE CALCULATION OF 7 | |
154 | - | THE INSURED’S OR ENROLLEE ’S CONTRIBUTION TO TH E INSURED’S OR ENROLLEE ’S 8 | |
155 | - | COINSURANCE , COPAYMENT , DEDUCTIBLE, OR OUT–OF–POCKET MAXIMUM SHALL 9 | |
156 | - | NOTIFY THE INSURED O R ENROLLEE OF : 10 | |
148 | + | (E) THE COMMISSIONER MAY ADOP T REGULATIONS TO CAR RY OUT THIS 6 | |
149 | + | SECTION. 7 | |
157 | 150 | ||
158 | - | (I) THE MAXIMUM DOLLAR A MOUNT OF THE DI SCOUNT, 11 | |
159 | - | FINANCIAL ASSISTANCE PAYMENT, PRODUCT VOUCHER , OR OTHER 12 | |
160 | - | OUT–OF–POCKET EXPENSE ; AND 13 | |
151 | + | 15–1601. 8 | |
161 | 152 | ||
162 | - | (II) THE EXPIRATION DATE FOR THE DISCOUNT , FINANCIAL 14 | |
163 | - | ASSISTANCE PAYMENT , PRODUCT VOUCHER , OR OTHER OUT –OF–POCKET EXPENSE . 15 | |
153 | + | (a) In this subtitle the following words have the meanings indicated. 9 | |
164 | 154 | ||
165 | - | ( | |
166 | - | ||
155 | + | (b) “Agent” means a pharmacy, a pharmacist, a mail order pharmacy, or a 10 | |
156 | + | nonresident pharmacy acting on behalf or at the direction of a pharmacy benefits manager. 11 | |
167 | 157 | ||
168 | - | ( | |
169 | - | ||
158 | + | (c) “Beneficiary” means an individual who receives prescription drug coverage or 12 | |
159 | + | benefits from a purchaser. 13 | |
170 | 160 | ||
171 | - | (2) “ADMINISTRATOR ” HAS THE MEANING STAT ED IN § 8–301 OF THIS 20 | |
172 | - | ARTICLE. 21 | |
161 | + | (d) (1) “Carrier” means the State Employee and Retiree Health and Welfare 14 | |
162 | + | Benefits Program, an insurer, a nonprofit health service plan, [or] a health maintenance 15 | |
163 | + | organization, OR ANY OTHER ENTITY SUBJECT TO THE JURIS DICTION OF THE 16 | |
164 | + | COMMISSIONER that: 17 | |
173 | 165 | ||
174 | - | (3) “CARRIER” MEANS AN ENTITY SUBJ ECT TO THE JURISDICTION OF 22 | |
175 | - | THE COMMISSIONER THAT CON TRACTS, OR OFFERS TO CONTRAC T, TO PROVIDE, 23 | |
176 | - | DELIVER, ARRANGE FOR , PAY FOR, OR REIMBURSE ANY OF THE COSTS OF HEALTH 24 | |
177 | - | CARE SERVICES UNDER A HEALTH BENEFIT PLA N IN THE STATE. 25 | |
166 | + | (i) provides prescription drug coverage or benefits in the State; and 18 | |
178 | 167 | ||
179 | - | (4) “COST SHARING ” MEANS ANY COPAYM ENT, COINSURANCE , 26 | |
180 | - | DEDUCTIBLE, OR OTHER SIMILAR CHA RGE REQUIRED OF AN E NROLLEE FOR A 27 | |
181 | - | HEALTH CARE SERVICE COVERED BY A HEALTH BENEFIT PLAN , INCLUDING A 28 | |
182 | - | PRESCRIPTION DRUG , AND PAID BY OR ON BE HALF OF THE ENROLLEE . 29 | |
168 | + | (ii) enters into an agreement with a pharmacy benefits manager for 19 | |
169 | + | the provision of pharmacy benefits management services. 20 | |
183 | 170 | ||
184 | - | (5) “ENROLLEE” MEANS AN INDIVIDUAL ENTITLED TO PAYMENT FOR 30 | |
185 | - | HEALTH CARE SERVICES FROM AN ADMINISTRATO R OR A CARRIER. 31 | |
171 | + | (2) “Carrier” does not include a person that provides prescription drug 21 | |
172 | + | coverage or benefits through plans subject to ERISA and does not provide prescription drug 22 | |
173 | + | coverage or benefits through insurance, unless the person is a multiple employer welfare 23 | |
174 | + | arrangement as defined in § 514(b)(6)(a)(ii) of ERISA. 24 | |
186 | 175 | ||
187 | - | (6) “HEALTH BENEFIT PLAN ” MEANS A POLICY , A CONTRACT , A 32 | |
188 | - | CERTIFICATION , OR AN AGREEMENT OFFE RED OR ISSUED BY AN ADMINISTRATOR 33 HOUSE BILL 879 5 | |
176 | + | (e) “Compensation program” means a program, policy, or process through which 25 | |
177 | + | sources and pricing information are used by a pharmacy benefits manager to determine the 26 | |
178 | + | terms of payment as stated in a participating pharmacy contract. 27 | |
179 | + | ||
180 | + | (f) “Contracted pharmacy” means a pharmacy that participates in the network of 28 | |
181 | + | a pharmacy benefits manager through a contract with: 29 | |
182 | + | ||
183 | + | (1) the pharmacy benefits manager; or 30 | |
184 | + | ||
185 | + | (2) a pharmacy services administration organization or a group purchasing 31 | |
186 | + | organization. 32 | |
187 | + | HOUSE BILL 879 5 | |
189 | 188 | ||
190 | 189 | ||
191 | - | OR A CARRIER TO PROV IDE, DELIVER, ARRANGE FOR , PAY FOR, OR REIMBURSE ANY 1 | |
192 | - | OF THE COSTS OF HEAL TH CARE SERVICES . 2 | |
190 | + | (G) “COST SHARING ” MEANS ANY COPAYMENT , COINSURANCE , 1 | |
191 | + | DEDUCTIBLE, OR OTHER SIMILAR CHA RGE REQUIRED OF A BENEFICIARY FOR A 2 | |
192 | + | HEALTH CARE SERVICE COVERED BY A HEALTH BENEFIT PLAN , INCLUDING A 3 | |
193 | + | PRESCRIPTION DRUG , AND PAID BY OR ON BE HALF OF THE BENEFICI ARY. 4 | |
193 | 194 | ||
194 | - | (7) “HEALTH CARE SERVICE ” MEANS AN ITEM OR SER VICE PROVIDED 3 | |
195 | - | TO AN INDIVIDUAL FOR THE PURPOSE OF PREVE NTING, ALLEVIATING, CURING, OR 4 | |
196 | - | HEALING HUMAN ILLNES S, INJURY, OR PHYSICAL DISABILI TY. 5 | |
195 | + | [(g)] (H) “ERISA” has the meaning stated in § 8–301 of this article. 5 | |
197 | 196 | ||
198 | - | (B) THE ANNUAL LIMITATION ON COST SHARING PROVIDE D FOR UNDER 42 6 | |
199 | - | U.S.C. § 18022(C)(1) SHALL APPLY TO ALL H EALTH CARE SERVICES COVERED 7 | |
200 | - | UNDER A HEALTH BENEF IT PLAN OFFERED OR I SSUED BY AN ADMINIST RATOR OR A 8 | |
201 | - | CARRIER IN THE STATE. 9 | |
197 | + | [(h)] (I) “Formulary” means a list of prescription drugs used by a purchaser. 6 | |
202 | 198 | ||
203 | - | (C) (1) SUBJECT TO PARAGRAPHS (2) AND (3) OF THIS SUBSECTION , 10 | |
204 | - | WHEN CALCULATING AN ENROLLEE’S CONTRIBUTION TO AN APPLICABLE COST 11 | |
205 | - | SHARING REQUIREMENT , AN ADMINISTRATOR OR A CARRIER SHALL INCL UDE COST 12 | |
206 | - | SHARING AMOUNTS PAID BY THE ENROLLEE OR O N BEHALF OF THE ENRO LLEE BY 13 | |
207 | - | ANOTHER PERSON . 14 | |
199 | + | (J) “HEALTH BENEFIT PLAN ” MEANS A POLICY , A CONTRACT , A 7 | |
200 | + | CERTIFICATION , OR AN AGREEMENT OFFE RED OR ISSUED BY AN ADMINISTRATOR 8 | |
201 | + | OR A CARRIER TO PROV IDE, DELIVER, ARRANGE FOR , PAY FOR, OR REIMBURSE ANY 9 | |
202 | + | PORTION OF THE COST OF HEALT H CARE SERVICES . 10 | |
208 | 203 | ||
209 | - | (2) IF THE APPLICATION OF THE REQUIREMENT UNDE R PARAGRAPH 15 | |
210 | - | (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS ACCOUNT 16 | |
211 | - | INELIGIBILITY UNDER § 223 OF THE INTERNAL REVENUE CODE, THE REQUIREMENT 17 | |
212 | - | SHALL APPLY TO HEALT H SAVINGS ACCOUNT –QUALIFIED HIGH DEDUC TIBLE 18 | |
213 | - | HEALTH PLANS WITH RESPE CT TO THE DEDUCTIBLE OF THE PLAN AFTER TH E 19 | |
214 | - | ENROLLEE SATISFIES T HE MINIMUM DEDUCTIBL E UNDER § 223 OF THE INTERNAL 20 | |
215 | - | REVENUE CODE. 21 | |
204 | + | (K) “HEALTH CARE SERVICE ” MEANS AN ITEM OR SER VICE PROVIDED TO AN 11 | |
205 | + | INDIVIDUAL FOR THE P URPOSE OF PREVENTING , ALLEVIATING, CURING, OR 12 | |
206 | + | HEALING HUMAN ILLNES S, INJURY, OR PHYSICAL DISABILI TY. 13 | |
216 | 207 | ||
217 | - | (3) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 22 | |
218 | - | ACCORDANCE WITH § 223(C)(2)(C) OF THE INTERNAL REVENUE CODE, THE 23 | |
219 | - | REQUIREMENTS OF THIS SUBSECTION SHALL APP LY REGARDLESS OF WHE THER THE 24 | |
220 | - | ENROLLEE SATISFIES T HE MINIMUM DEDUCTIBL E UNDER § 223 OF THE INTERNAL 25 | |
221 | - | REVENUE CODE. 26 | |
208 | + | [(i)] (L) (1) “Manufacturer payments” means any compensation or 14 | |
209 | + | remuneration a pharmacy benefits manager receives from or on behalf of a pharmaceutical 15 | |
210 | + | manufacturer. 16 | |
222 | 211 | ||
223 | - | (D) AN ADMINISTRATOR OR A CARRIER MAY NOT DIRE CTLY OR INDIRECTLY 27 | |
224 | - | SET, ALTER, IMPLEMENT, OR CONDITION THE TER MS OF HEALTH BENEFIT PLAN 28 | |
225 | - | COVERAGE, INCLUDING THE BENEFI T DESIGN, BASED IN WHOLE OR IN PART ON 29 | |
226 | - | INFORMATION ABOUT TH E AVAILABILITY OR AM OUNT OF FINANCIAL OR PRODUCT 30 | |
227 | - | ASSISTANCE AVAILABLE FOR A PRESCRIPTION D RUG. 31 | |
212 | + | (2) “Manufacturer payments” includes: 17 | |
228 | 213 | ||
229 | - | ( | |
230 | - | ||
214 | + | (i) payments received in accordance with agreements with 18 | |
215 | + | pharmaceutical manufacturers for formulary placement and, if applicable, drug utilization; 19 | |
231 | 216 | ||
232 | - | 15–1601. 34 | |
217 | + | (ii) rebates, regardless of how categorized; 20 | |
218 | + | ||
219 | + | (iii) market share incentives; 21 | |
220 | + | ||
221 | + | (iv) commissions; 22 | |
222 | + | ||
223 | + | (v) fees under products and services agreements; 23 | |
224 | + | ||
225 | + | (vi) any fees received for the sale of utilization data to a 24 | |
226 | + | pharmaceutical manufacturer; and 25 | |
227 | + | ||
228 | + | (vii) administrative or management fees. 26 | |
229 | + | ||
230 | + | (3) “Manufacturer payments” does not include purchase discounts based on 27 | |
231 | + | invoiced purchase terms. 28 | |
232 | + | ||
233 | + | [(j)] (M) “Nonprofit health maintenance organization” has the meaning stated 29 | |
234 | + | in § 6–121(a) of this article. 30 | |
233 | 235 | 6 HOUSE BILL 879 | |
234 | 236 | ||
235 | 237 | ||
236 | - | (a) In this subtitle the following words have the meanings indicated. 1 | |
238 | + | [(k)] (N) “Nonresident pharmacy” has the meaning stated in § 12–403 of the 1 | |
239 | + | Health Occupations Article. 2 | |
237 | 240 | ||
238 | - | ( | |
239 | - | ||
241 | + | [(l)] (O) “Participating pharmacy contract” means a contract filed with the 3 | |
242 | + | Commissioner in accordance with § 15–1628(b) of this subtitle. 4 | |
240 | 243 | ||
241 | - | ( | |
242 | - | ||
244 | + | [(m)] (P) “Pharmacist” has the meaning stated in § 12–101 of the Health 5 | |
245 | + | Occupations Article. 6 | |
243 | 246 | ||
244 | - | (d) (1) “Carrier” means the State Employee and Retiree Health and Welfare 6 | |
245 | - | Benefits Program, an insurer, a nonprofit health service plan, [or] a health maintenance 7 | |
246 | - | organization, OR ANY OTHER ENTITY SUBJECT TO THE JURIS DICTION OF THE 8 | |
247 | - | COMMISSIONER that: 9 | |
247 | + | [(n)] (Q) “Pharmacy” has the meaning stated in § 12 –101 of the Health 7 | |
248 | + | Occupations Article. 8 | |
248 | 249 | ||
249 | - | (i) provides prescription drug coverage or benefits in the State; and 10 | |
250 | + | [(o)] (R) “Pharmacy and therapeutics committee” means a committee 9 | |
251 | + | established by a pharmacy benefits manager to: 10 | |
250 | 252 | ||
251 | - | (ii) enters into an agreement with a pharmacy benefits manager for 11 | |
252 | - | the provision of pharmacy benefits management services. 12 | |
253 | + | (1) objectively appraise and evaluate prescription drugs; and 11 | |
253 | 254 | ||
254 | - | (2) “Carrier” does not include a person that provides prescription drug 13 | |
255 | - | coverage or benefits through plans subject to ERISA and does not provide prescription drug 14 | |
256 | - | coverage or benefits through insurance, unless the person is a multiple employer welfare 15 | |
257 | - | arrangement as defined in § 514(b)(6)(a)(ii) of ERISA. 16 | |
255 | + | (2) make recommendations to a purchaser regarding the selection of drugs 12 | |
256 | + | for the purchaser’s formulary. 13 | |
258 | 257 | ||
259 | - | (e) “Compensation program” means a program, policy, or process through which 17 | |
260 | - | sources and pricing information are used by a pharmacy benefits manager to determine the 18 | |
261 | - | terms of payment as stated in a participating pharmacy contract. 19 | |
258 | + | [(p)] (S) (1) “Pharmacy benefits management services” means: 14 | |
262 | 259 | ||
263 | - | (f) “Contracted pharmacy” means a pharmacy that participates in the network of 20 | |
264 | - | a pharmacy benefits manager through a contract with: 21 | |
260 | + | (i) the [procurement of prescription drugs at a negotiated rate for 15 | |
261 | + | dispensation within the State to beneficiaries] NEGOTIATION OF THE P RICE OF 16 | |
262 | + | PRESCRIPTION DRUGS , INCLUDING THE NEGOTI ATING AND CONTRACTIN G FOR 17 | |
263 | + | DIRECT AND INDIRECT REBATES, DISCOUNTS, OR OTHER PRICE CONCE SSIONS; 18 | |
265 | 264 | ||
266 | - | (1) the pharmacy benefits manager; or 22 | |
265 | + | (ii) the administration or management of prescription drug coverage 19 | |
266 | + | provided by a purchaser for beneficiaries; [and] 20 | |
267 | 267 | ||
268 | - | ( | |
269 | - | ||
268 | + | (iii) any of the following services provided with regard to the 21 | |
269 | + | administration of prescription drug coverage: 22 | |
270 | 270 | ||
271 | - | (G) “COST SHARING ” MEANS ANY COPAYMENT , COINSURANCE , 25 | |
272 | - | DEDUCTIBLE, OR OTHER SIMILAR CHA RGE REQUIRED OF A BE NEFICIARY FOR A 26 | |
273 | - | HEALTH CARE SERVICE COVERED BY A HEALTH BENEFIT PLAN , INCLUDING A 27 | |
274 | - | PRESCRIPTION DRUG , AND PAID BY OR ON BE HALF OF THE BENEFICI ARY. 28 | |
271 | + | 1. mail service pharmacy; 23 | |
275 | 272 | ||
276 | - | [(g)] (H) “ERISA” has the meaning stated in § 8–301 of this article. 29 | |
273 | + | 2. claims processing, retail network management, and 24 | |
274 | + | payment of claims to pharmacies for prescription drugs dispensed to beneficiaries; 25 | |
277 | 275 | ||
278 | - | | |
276 | + | 3. clinical formulary development and management services; 26 | |
279 | 277 | ||
280 | - | (J) “HEALTH BENEFIT PLAN ” MEANS A POLICY , A CONTRACT , A 31 | |
281 | - | CERTIFICATION , OR AN AGREEMENT OFFE RED OR ISSUED BY AN ADMINISTRATOR 32 HOUSE BILL 879 7 | |
278 | + | 4. rebate contracting and administration; 27 | |
279 | + | ||
280 | + | 5. patient compliance, therapeutic intervention, and generic 28 | |
281 | + | substitution programs; [or] 29 | |
282 | + | ||
283 | + | 6. disease management programs; 30 HOUSE BILL 879 7 | |
282 | 284 | ||
283 | 285 | ||
284 | - | OR A CARRIER TO PROV IDE, DELIVER, ARRANGE FOR , PAY FOR, OR REIMBURSE ANY 1 | |
285 | - | PORTION OF THE COST OF HEALTH CARE SERVICES . 2 | |
286 | 286 | ||
287 | - | (K) “HEALTH CARE SERVICE ” MEANS AN ITEM OR SER VICE PROVIDED TO AN 3 | |
288 | - | INDIVIDUAL FOR THE P URPOSE OF PREVENTING , ALLEVIATING, CURING, OR 4 | |
289 | - | HEALING HUMAN ILLNES S, INJURY, OR PHYSICAL DISABILI TY. 5 | |
287 | + | 7. DRUG UTILIZATION REV IEW; OR 1 | |
290 | 288 | ||
291 | - | [(i)] (L) (1) “Manufacturer payments” means any compensation or 6 | |
292 | - | remuneration a pharmacy benefits manager receives from or on behalf of a pharmaceutical 7 | |
293 | - | manufacturer. 8 | |
289 | + | 8. ADJUDICATION OF APPE ALS OR GRIEVANCES 2 | |
290 | + | RELATED TO A PRESCRI PTION DRUG BENEFIT ; 3 | |
294 | 291 | ||
295 | - | (2) “Manufacturer payments” includes: 9 | |
292 | + | (IV) THE PERFORMANCE OF A DMINISTRATIVE , MANAGERIAL , 4 | |
293 | + | CLINICAL, PRICING, FINANCIAL, REIMBURSEMENT , DATA ADMINISTRATION OR 5 | |
294 | + | REPORTING, OR BILLING SERVICES ; OR 6 | |
296 | 295 | ||
297 | - | ( | |
298 | - | ||
296 | + | (V) OTHER SERVICES DEFIN ED BY THE COMMISSIONER IN 7 | |
297 | + | REGULATION . 8 | |
299 | 298 | ||
300 | - | (ii) rebates, regardless of how categorized; 12 | |
299 | + | (2) “Pharmacy benefits management services” does not include any service 9 | |
300 | + | provided by a nonprofit health maintenance organization that operates as a group model, 10 | |
301 | + | provided that the service: 11 | |
301 | 302 | ||
302 | - | (iii) market share incentives; 13 | |
303 | + | (i) is provided solely to a member of the nonprofit health 12 | |
304 | + | maintenance organization; and 13 | |
303 | 305 | ||
304 | - | (iv) commissions; 14 | |
306 | + | (ii) is furnished through the internal pharmacy operations of the 14 | |
307 | + | nonprofit health maintenance organization. 15 | |
305 | 308 | ||
306 | - | ( | |
309 | + | [(q)] (T) “Pharmacy benefits manager” means: 16 | |
307 | 310 | ||
308 | - | (vi) any fees received for the sale of utilization data to a 16 | |
309 | - | pharmaceutical manufacturer; and 17 | |
311 | + | (1) a person that [performs], IN ACCORDANCE WITH A WRITTEN 17 | |
312 | + | AGREEMENT WITH A PUR CHASER, EITHER DIRECTLY OR I NDIRECTLY, PROVIDES 18 | |
313 | + | ONE OR MORE pharmacy benefits management services; OR 19 | |
310 | 314 | ||
311 | - | (vii) administrative or management fees. 18 | |
315 | + | (2) AN AGENT OR OTHER PR OXY OR REPRESENTATIV E, CONTRACTOR , 20 | |
316 | + | INTERMEDIARY , AFFILIATE, SUBSIDIARY, OR RELATED ENTITY OF A PERSON THAT 21 | |
317 | + | FACILITATES, PROVIDES, DIRECTS, OR OVERSEES THE PROV ISION OF PHARMACY 22 | |
318 | + | BENEFITS MANAGEMENT SERVICES. 23 | |
312 | 319 | ||
313 | - | (3) “Manufacturer payments” does not include purchase discounts based on 19 | |
314 | - | invoiced purchase terms. 20 | |
320 | + | [(r)] (U) “Proprietary information” means: 24 | |
315 | 321 | ||
316 | - | [(j)] (M) “Nonprofit health maintenance organization” has the meaning stated 21 | |
317 | - | in § 6–121(a) of this article. 22 | |
322 | + | (1) a trade secret; 25 | |
318 | 323 | ||
319 | - | [(k)] (N) “Nonresident pharmacy” has the meaning stated in § 12–403 of the 23 | |
320 | - | Health Occupations Article. 24 | |
324 | + | (2) confidential commercial information; or 26 | |
321 | 325 | ||
322 | - | [(l)] (O) “Participating pharmacy contract” means a contract filed with the 25 | |
323 | - | Commissioner in accordance with § 15–1628(b) of this subtitle. 26 | |
326 | + | (3) confidential financial information. 27 | |
324 | 327 | ||
325 | - | [( | |
326 | - | ||
328 | + | [(s)] (V) “Purchaser” means a person that offers a plan or program in the State, 28 | |
329 | + | including the State Employee and Retiree Health and Welfare Benefits Program, that: 29 | |
327 | 330 | 8 HOUSE BILL 879 | |
328 | 331 | ||
329 | 332 | ||
330 | - | [(n)] (Q) “Pharmacy” has the meaning stated in § 12 –101 of the Health 1 | |
331 | - | Occupations Article. 2 | |
333 | + | (1) provides prescription drug coverage or benefits in the State; and 1 | |
332 | 334 | ||
333 | - | ||
334 | - | ||
335 | + | (2) enters into an agreement with a pharmacy benefits manager for the 2 | |
336 | + | provision of pharmacy benefits management services. 3 | |
335 | 337 | ||
336 | - | (1) objectively appraise and evaluate prescription drugs; and 5 | |
338 | + | [(t)] (W) “Rebate sharing contract” means a contract between a pharmacy 4 | |
339 | + | benefits manager and a purchaser under which the pharmacy benefits manager agrees to 5 | |
340 | + | share manufacturer payments with the purchaser. 6 | |
337 | 341 | ||
338 | - | ( | |
339 | - | ||
342 | + | [(u)] (X) (1) “Therapeutic interchange” means any change from one 7 | |
343 | + | prescription drug to another. 8 | |
340 | 344 | ||
341 | - | ||
345 | + | (2) “Therapeutic interchange” does not include: 9 | |
342 | 346 | ||
343 | - | (i) the [procurement of prescription drugs at a negotiated rate for 9 | |
344 | - | dispensation within the State to beneficiaries] NEGOTIATION OF THE P RICE OF 10 | |
345 | - | PRESCRIPTION DRUGS , INCLUDING THE NEGOTIAT ING AND CONTRACTING FOR 11 | |
346 | - | DIRECT AND INDIRECT REBATES, DISCOUNTS, OR OTHER PRICE CONCE SSIONS; 12 | |
347 | + | (i) a change initiated pursuant to a drug utilization review; 10 | |
347 | 348 | ||
348 | - | (ii) the administration or management of prescription drug coverage 13 | |
349 | - | provided by a purchaser for beneficiaries; [and] 14 | |
349 | + | (ii) a change initiated for patient safety reasons; 11 | |
350 | 350 | ||
351 | - | (iii) | |
352 | - | ||
351 | + | (iii) a change required due to market unavailability of the currently 12 | |
352 | + | prescribed drug; 13 | |
353 | 353 | ||
354 | - | 1. mail service pharmacy; 17 | |
354 | + | (iv) a change from a brand name drug to a generic drug in accordance 14 | |
355 | + | with § 12–504 of the Health Occupations Article; or 15 | |
355 | 356 | ||
356 | - | | |
357 | - | ||
357 | + | (v) a change required for coverage reasons because the originally 16 | |
358 | + | prescribed drug is not covered by the beneficiary’s formulary or plan. 17 | |
358 | 359 | ||
359 | - | 3. clinical formulary development and management services; 20 | |
360 | + | [(v)] (Y) “Therapeutic interchange solicitation” means any communication by a 18 | |
361 | + | pharmacy benefits manager for the purpose of requesting a therapeutic interchange. 19 | |
360 | 362 | ||
361 | - | 4. rebate contracting and administration; 21 | |
363 | + | [(w)] (Z) “Trade secret” has the meaning stated in § 11–1201 of the Commercial 20 | |
364 | + | Law Article. 21 | |
362 | 365 | ||
363 | - | 5. patient compliance, therapeutic intervention, and generic 22 | |
364 | - | substitution programs; [or] 23 | |
366 | + | 15–1611.3. 22 | |
365 | 367 | ||
366 | - | 6. disease management programs; 24 | |
368 | + | (A) THIS SECTION APPLIES ONLY TO A PHARMACY B ENEFITS MANAGER 23 | |
369 | + | THAT PROVIDES PHARMA CY BENEFITS MANAGEME NT SERVICES ON BEHAL F OF A 24 | |
370 | + | CARRIER. 25 | |
367 | 371 | ||
368 | - | 7. DRUG UTILIZATION REV IEW; OR 25 | |
369 | - | ||
370 | - | 8. ADJUDICATION OF APPE ALS OR GRIEVANCES 26 | |
371 | - | RELATED TO A PRESCRI PTION DRUG BENEFIT ; 27 | |
372 | + | (B) (1) SUBJECT TO PARAGRAPHS (2) AND (3) OF THIS SUBSECTION , 26 | |
373 | + | WHEN CALCULATING A B ENEFICIARY’S CONTRIBUTION TO AN APPLICABLE COST 27 | |
374 | + | SHARING REQUIREMENT , A PHARMACY BENEFITS MANAGER SHALL INCLUD E COST 28 | |
375 | + | SHARING AMOUNTS PAID BY THE BENEFICIARY O N BEHALF OF THE BENE FICIARY BY 29 | |
376 | + | ANOTHER PERSON . 30 | |
372 | 377 | HOUSE BILL 879 9 | |
373 | 378 | ||
374 | 379 | ||
375 | - | (IV) THE PERFORMANCE OF A DMINISTRATIVE , MANAGERIAL , 1 | |
376 | - | CLINICAL, PRICING, FINANCIAL, REIMBURSEMENT , DATA ADMINISTRATION OR 2 | |
377 | - | REPORTING, OR BILLING SERVICES; OR 3 | |
378 | - | ||
379 | - | (V) OTHER SERVICES DEFIN ED BY THE COMMISSIONER IN 4 | |
380 | - | REGULATION . 5 | |
381 | - | ||
382 | - | (2) “Pharmacy benefits management services” does not include any service 6 | |
383 | - | provided by a nonprofit health maintenance organization that operates as a group model, 7 | |
384 | - | provided that the service: 8 | |
385 | - | ||
386 | - | (i) is provided solely to a member of the nonprofit health 9 | |
387 | - | maintenance organization; and 10 | |
388 | - | ||
389 | - | (ii) is furnished through the internal pharmacy operations of the 11 | |
390 | - | nonprofit health maintenance organization. 12 | |
391 | - | ||
392 | - | [(q)] (T) “Pharmacy benefits manager” means: 13 | |
393 | - | ||
394 | - | (1) a person that [performs], IN ACCORDANCE WITH A WRITTEN 14 | |
395 | - | AGREEMENT WITH A PUR CHASER, EITHER DIRECTLY OR I NDIRECTLY, PROVIDES 15 | |
396 | - | ONE OR MORE pharmacy benefits management services; OR 16 | |
397 | - | ||
398 | - | (2) AN AGENT OR OTHER PR OXY OR REPRESENTATIVE , CONTRACTOR , 17 | |
399 | - | INTERMEDIARY , AFFILIATE, SUBSIDIARY, OR RELATED ENTITY OF A PERSON THAT 18 | |
400 | - | FACILITATES, PROVIDES, DIRECTS, OR OVERSEES THE PROV ISION OF PHARMACY 19 | |
401 | - | BENEFITS MANAGEMENT SERVICES. 20 | |
402 | - | ||
403 | - | [(r)] (U) “Proprietary information” means: 21 | |
404 | - | ||
405 | - | (1) a trade secret; 22 | |
406 | - | ||
407 | - | (2) confidential commercial information; or 23 | |
408 | - | ||
409 | - | (3) confidential financial information. 24 | |
410 | - | ||
411 | - | [(s)] (V) “Purchaser” means a person that offers a plan or program in the State, 25 | |
412 | - | including the State Employee and Retiree Health and Welfare Benefits Program, that: 26 | |
413 | - | ||
414 | - | (1) provides prescription drug coverage or benefits in the State; and 27 | |
415 | - | ||
416 | - | (2) enters into an agreement with a pharmacy benefits manager for the 28 | |
417 | - | provision of pharmacy benefits management services. 29 | |
418 | - | 10 HOUSE BILL 879 | |
419 | - | ||
420 | - | ||
421 | - | [(t)] (W) “Rebate sharing contract” means a contract between a pharmacy 1 | |
422 | - | benefits manager and a purchaser under which the pharmacy benefits manager agrees to 2 | |
423 | - | share manufacturer payments with the purchaser. 3 | |
424 | - | ||
425 | - | [(u)] (X) (1) “Therapeutic interchange” means any change from one 4 | |
426 | - | prescription drug to another. 5 | |
427 | - | ||
428 | - | (2) “Therapeutic interchange” does not include: 6 | |
429 | - | ||
430 | - | (i) a change initiated pursuant to a drug utilization review; 7 | |
431 | - | ||
432 | - | (ii) a change initiated for patient safety reasons; 8 | |
433 | - | ||
434 | - | (iii) a change required due to market unavailability of the currently 9 | |
435 | - | prescribed drug; 10 | |
436 | - | ||
437 | - | (iv) a change from a brand name drug to a generic drug in accordance 11 | |
438 | - | with § 12–504 of the Health Occupations Article; or 12 | |
439 | - | ||
440 | - | (v) a change required for coverage reasons because the originally 13 | |
441 | - | prescribed drug is not covered by the beneficiary’s formulary or plan. 14 | |
442 | - | ||
443 | - | [(v)] (Y) “Therapeutic interchange solicitation” means any communication by a 15 | |
444 | - | pharmacy benefits manager for the purpose of requesting a therapeutic interchange. 16 | |
445 | - | ||
446 | - | [(w)] (Z) “Trade secret” has the meaning stated in § 11–1201 of the Commercial 17 | |
447 | - | Law Article. 18 | |
448 | - | ||
449 | - | 15–1611.3. 19 | |
450 | - | ||
451 | - | (A) THIS SECTION APPLIES ONLY TO A PHARMACY B ENEFITS MANAGER 20 | |
452 | - | THAT PROVIDES PHARMA CY BENEFITS MANAGEME NT SERVICES ON BEHAL F OF A 21 | |
453 | - | CARRIER. 22 | |
454 | - | ||
455 | - | (B) (1) SUBJECT TO PARAGRAPHS (2) AND (3) OF THIS SUBSECTION , 23 | |
456 | - | WHEN CALCULATING A B ENEFICIARY’S CONTRIBUTION TO AN APPLICABLE COST 24 | |
457 | - | SHARING REQUIREMENT , A PHARMACY BENEFITS MANAGER SHALL INCLUD E COST 25 | |
458 | - | SHARING AMOUNTS PAID BY THE BENEFICIARY O N BEHALF OF THE BENE FICIARY BY 26 | |
459 | - | ANOTHER PERSON . 27 | |
460 | - | ||
461 | - | (2) IF THE APPLICATION OF THE REQUIREMENT UNDE R PARAGRAPH 28 | |
462 | - | (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS ACCOUNT 29 | |
463 | - | INELIGIBILITY UNDER § 223 OF THE INTERNAL REVENUE CODE, THE REQUIREMENT 30 | |
464 | - | SHALL APPLY TO HEALT H SAVINGS ACCOUNT –QUALIFIED HIGH DEDUC TIBLE 31 | |
465 | - | HEALTH PLANS WITH RE SPECT TO THE DEDUCTI BLE OF THE PLAN AFTE R THE 32 HOUSE BILL 879 11 | |
466 | - | ||
467 | - | ||
468 | - | BENEFICIARY SATISFIE S THE MINIMUM DEDUCT IBLE UNDER § 223 OF THE 1 | |
469 | - | INTERNAL REVENUE CODE. 2 | |
470 | - | ||
471 | - | (3) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 3 | |
472 | - | ACCORDANCE WITH § 223(C)(2)(C) OF THE INTERNAL REVENUE CODE, THE 4 | |
473 | - | REQUIREMENTS OF THIS SUBSECTION SHALL APP LY REGARDLESS OF WHE THER THE 5 | |
380 | + | (2) IF THE APPLICATION OF THE R EQUIREMENT UNDER PAR AGRAPH 1 | |
381 | + | (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS ACCOUNT 2 | |
382 | + | INELIGIBILITY UNDER § 223 OF THE INTERNAL REVENUE CODE, THE REQUIREMENT 3 | |
383 | + | SHALL APPLY TO HEALT H SAVINGS ACCOUNT –QUALIFIED HIGH DEDUC TIBLE 4 | |
384 | + | HEALTH PLAN S WITH RESPECT TO TH E DEDUCTIBLE OF THE PLAN AFTER THE 5 | |
474 | 385 | BENEFICIARY SATISFIE S THE MINIMUM DEDUCT IBLE UNDER § 223 OF THE 6 | |
475 | 386 | INTERNAL REVENUE CODE. 7 | |
476 | 387 | ||
477 | - | ( | |
478 | - | ||
479 | - | ||
480 | - | ||
481 | - | ||
388 | + | (3) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 8 | |
389 | + | ACCORDANCE WITH § 223(C)(2)(C) OF THE INTERNAL REVENUE CODE, THE 9 | |
390 | + | REQUIREMENTS OF THIS SUBSECTION SHALL APP LY REGARDLESS OF WHE THER THE 10 | |
391 | + | BENEFICIARY SATISFIE S THE MINIMUM DEDUCT IBLE UNDER § 223 OF THE 11 | |
392 | + | INTERNAL REVENUE CODE. 12 | |
482 | 393 | ||
483 | - | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 13 | |
484 | - | policies, contracts, and health plans issued, delivered, or renewed in the State on or after 14 | |
485 | - | January 1, 2025. 15 | |
394 | + | (C) A PHARMACY BENEFITS MA NAGER MAY NOT DIRECT LY OR INDIRECTLY 13 | |
395 | + | SET, ALTER, IMPLEMENT, OR CONDITION THE TERM S OF HEALTH BENEFIT PLAN 14 | |
396 | + | COVERAGE, INCLUDING THE BENEFI T DESIGN, BASED IN WHOLE OR IN PART ON 15 | |
397 | + | INFORMATION ABOUT TH E AVAILABILITY OR AM OUNT OF FINANCIAL OR PRODUCT 16 | |
398 | + | ASSISTANCE AVAILABLE FOR A PRESCRIPTION D RUG. 17 | |
486 | 399 | ||
487 | - | SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 16 | |
488 | - | January 1, 2025. 17 | |
400 | + | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 18 | |
401 | + | policies, contracts, and health plans issued, delivered, or renewed in the State on or after 19 | |
402 | + | January 1, 2025. 20 | |
489 | 403 | ||
404 | + | SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 21 | |
405 | + | January 1, 2025. 22 | |
490 | 406 | ||
491 | - | ||
492 | - | Approved: | |
493 | - | ________________________________________________________________________________ | |
494 | - | Governor. | |
495 | - | ________________________________________________________________________________ | |
496 | - | Speaker of the House of Delegates. | |
497 | - | ________________________________________________________________________________ | |
498 | - | President of the Senate. |